Table 1.
MICs (Minimum Inhibitory Concentrations) of tested antifungal agents for six Candida auris isolated from five patients with comorbidity diseases.
| Antifungal Agent | Isolates | |||||
|---|---|---|---|---|---|---|
| CA1 | CA3 | CA4 | CA5 | CA7 | CA8 | |
| Sex | Male | Male | Male | Male | Male | |
| Age | 62 | 85 | 26 | 77 | 68 | |
| Medical condition | DM, HTN, CAD, right MCA stroke | DM, HTN, COPD, CVA | Brain stem haemorrhage | DM, HTN, chronic anaemia, ischaemic stroke, subarachnoid haemorrhage | DM, HTN, post cardiac valve replacement | |
| Specimen | Urine | Urine | Groin | Blood | Urine | Ear swab |
| Amphotericin B | 0.5 | 8 | 0.5 | 8 | 8 | 0.5 |
| Fluconazole | 16 | 32 | 32 | 32 | 32 | 8 |
| Voriconazole | 0.5 | 0.5 | 0.5 | R–1 | 1 | ≥8 |
| Caspofungin | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Micafungin | ≤0.06 | ≤0.06 | ≤0.06 | ≤0.06 | ≤0.06 | ≤0.06 |
| Flucytosine | ≤1 | S–≤ 1 | S–≤ 1 | S–≤ 1 | S–≤ 1 | S–≤ 1 |
DM: Diabetes, HTN: Hypertension, CAD: Chronic artery disease, MCA: Middle cerebral artery, COPD: Chronic obstructive pulmonary disease, CVA: Cerebrovascular stroke.